Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation

被引:13
|
作者
Gazourian, Lee [1 ]
Coronata, Anna Maria F. [1 ]
Rogers, Angela J. [1 ,2 ]
Weinhouse, Gerald L. [1 ]
Soiffer, Robert J. [3 ]
Antin, Joseph H. [3 ]
Ritz, Jerome [3 ]
Ho, Vincent T. [3 ]
Baron, Rebecca M. [1 ]
Washko, George R. [1 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Med Oncol, Div Hematol Malignancies, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Computed tomography; Bone marrowtransplantation; Bronchiolitis obliterans syndrome; Airway disease; BONE-MARROW-TRANSPLANTATION; THIN-SECTION CT; RESOLUTION COMPUTED-TOMOGRAPHY; OBSTRUCTIVE LUNG-DISEASE; VERSUS-HOST-DISEASE; FLOW OBSTRUCTION; RISK-FACTORS; RECIPIENTS; DIMENSIONS; EMPHYSEMA;
D O I
10.1016/j.rmed.2012.11.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Bronchiolitis obliterans syndrome (BOS) is a late, non-infectious pulmonary complication following hematopoietic stem cell transplantation (HSCT). There is minimal data published on quantitative radiologic characterization of airway remodeling in these subjects. Objectives: To examine quantitative measurements of airway morphology and their correlation with lung function in a cohort of patients who underwent HSCT and developed BOS. Methods: All adult patients who underwent allogeneic HSCT at the Dana-Farber Cancer Institute/Brigham and Women's Hospital (n = 1854) between January 1st 2000 and June 30th 2010 were screened for the development of BOS. Clinically acquired high resolution CT (HRCT) scans of the chest were collected. For each subjects discrete measures of airway wall area were performed and the square root of wall area of a 10-mm luminal perimeter (Pi 10) was calculated. Measurements and main results: We identified 88 cases of BOS, and 37 of these patients had available HRCT. On CT scans obtained after BOS diagnosis, the Pi10 decreased (consistent with airway dilation) as compared with pre-BOS values (p < 0.001). After HSCT the Pi10 correlated with FEV1% predicted (r = 0.636, p < 0.0001), and RV/TLC% predicted (r = -0.736, p < 0.0001), even after adjusting for age, sex and total lung capacity (p < 0.0001 for both). Conclusions: On HRCT scan BOS is characterized by central airway dilation, the degree of which is correlated to decrements in lung function. This is opposite of what has been previously demonstrated in COPD and asthma that quantitative measure of proximal airway wall thickening directly correlate with pulmonary function. Our data suggests that the pathologic process affecting the central airways is different from the pathology observed in the distal airways. Further work is needed to determine if such change can be used as a sensitive and specific tool for the future diagnosis and staging of BOS. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 50 条
  • [21] Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation
    Mo Xiao-dong
    Xu Lan-ping
    Liu Dai-hong
    Zhang Xiao-hui
    Chen Huan
    Chen Yu-hong
    Han Wei
    Wang Yu
    Wang Feng-rong
    Wang Jing-zhi
    Liu Kai-yan
    Huang Xiao-jun
    CHINESE MEDICAL JOURNAL, 2013, 126 (13) : 2489 - 2494
  • [22] Lung transplantation for Bronchiolitis obliterans syndrome after allogeneic stem cell transplantation
    Holm, A.
    Riise, G.
    Hansson, L.
    Brinch, L.
    Bjortuft, O.
    Simonsen, S.
    Floisand, Y.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S337 - S337
  • [23] AIRWAY FUNCTION IN PATIENTS WITH BRONCHIOLITIS OBLITERANS FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT)
    Schoeffel, R.
    Htun, C.
    Taylor, J.
    Greenwood, M.
    King, G.
    RESPIROLOGY, 2014, 19 : 11 - 11
  • [24] Lung Transplantation for Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
    Vogl, Ursula M.
    Nagayama, Kazuhiro
    Bojic, Marija
    Hoda, Mir Ali Reza
    Klepetko, Walter
    Jaksch, Peter
    Dekan, Sabine
    Siersch, Viktoria
    Mitterbauer, Margit
    Schellongowski, Peter
    Greinix, Hildegard T.
    Petkov, Ventzislav
    Schulenburg, Axel
    Kalhs, Peter
    Rabitsch, Werner
    TRANSPLANTATION, 2013, 95 (04) : 623 - 628
  • [25] Bronchiolitis obliterans organising pneumonia after allogeneic stem cell transplantation
    Peceny, R
    Elmaagacli, AH
    Ottinger, H
    Trenschel, R
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2005, 35 : S60 - S60
  • [26] Authors' Reply: Lung Transplantation for Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation: Unresolved Questions
    Vogl, Ursula M.
    Nagayama, Kazuhiro
    Rabitsch, Werner
    TRANSPLANTATION, 2013, 96 (04) : E22 - E22
  • [27] Bronchiolitis Obliterans Syndrome and Other Late Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation
    Bergeron, Anne
    Cheng, Guang-Shing
    CLINICS IN CHEST MEDICINE, 2017, 38 (04) : 607 - +
  • [28] Budesonide/Formoterol for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation
    Bergeron, Anne
    Chevret, Sylvie
    Chagnon, Karine
    Godet, Cendrine
    Bergot, Emmanuel
    de Latour, Regis Peffault
    Dominique, Stephane
    de Revel, Thierry
    Juvin, Karine
    Maillard, Natacha
    Reman, Oumedaly
    Contentin, Nathalie
    Robin, Marie
    Buzyn, Agnes
    Socie, Gerard
    Tazi, Abdellatif
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (11) : 1242 - 1249
  • [29] Preventing and managing bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation
    Chien, Jason W.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (01) : 127 - 135
  • [30] Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantation
    Taiga Kuroi
    Nobuharu Fujii
    Koichi Ichimura
    Keisuke Seike
    Akira Yamamoto
    Yui Kambara
    Seiichiro Sugimoto
    Shinji Otani
    Kyosuke Saeki
    Hideaki Fujiwara
    Hisakazu Nishiomori
    Takahiro Oto
    Yoshinobu Maeda
    International Journal of Hematology, 2021, 114 : 701 - 708